Re-irradiation combined with bevacizumab for recurrent glioblastoma beyond bevacizumab failure: survival outcomes and prognostic factors

The combination of re-irradiation and bevacizumab has emerged as a potential therapeutic strategy for patients experiencing their first glioblastoma multiforme (GBM) recurrence. This study aims to assess the effectiveness of the re-irradiation and bevacizumab combination in treating second-progressi...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Weir-Chiang, Lee, Hsu-Dung, Pan, Hung-Chuan, Chen, Hung-Chieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256803/
https://www.ncbi.nlm.nih.gov/pubmed/37296207
http://dx.doi.org/10.1038/s41598-023-36290-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256803/
https://www.ncbi.nlm.nih.gov/pubmed/37296207
http://dx.doi.org/10.1038/s41598-023-36290-2

Ejemplares similares